IRIS Accounts Production v25.4.0.155 06988872 Board of Directors 1.4.24 31.3.25 31.3.25 false true false false true false 4174 3944 8118 4174 4174 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh069888722024-03-31069888722025-03-31069888722024-04-012025-03-31069888722023-03-31069888722023-04-012024-03-31069888722024-03-3106988872ns15:EnglandWales2024-04-012025-03-3106988872ns14:PoundSterling2024-04-012025-03-3106988872ns10:Director12024-04-012025-03-3106988872ns10:PrivateLimitedCompanyLtd2024-04-012025-03-3106988872ns10:SmallEntities2024-04-012025-03-3106988872ns10:AuditExempt-NoAccountantsReport2024-04-012025-03-3106988872ns10:SmallCompaniesRegimeForDirectorsReport2024-04-012025-03-3106988872ns10:SmallCompaniesRegimeForAccounts2024-04-012025-03-3106988872ns10:FullAccounts2024-04-012025-03-3106988872ns10:Director1412024-03-3106988872ns10:Director1412023-03-3106988872ns10:Director1412023-04-012024-03-3106988872ns10:Director1412024-04-012025-03-3106988872ns10:Director1412024-03-3106988872ns10:Director22024-04-012025-03-3106988872ns10:Director32024-04-012025-03-3106988872ns10:RegisteredOffice2024-04-012025-03-3106988872ns5:CurrentFinancialInstruments2025-03-3106988872ns5:CurrentFinancialInstruments2024-03-3106988872ns5:ShareCapital2025-03-3106988872ns5:ShareCapital2024-03-3106988872ns5:RetainedEarningsAccumulatedLosses2025-03-3106988872ns5:RetainedEarningsAccumulatedLosses2024-03-3106988872ns5:PlantMachinery2024-04-012025-03-3106988872ns5:ComputerEquipment2024-04-012025-03-3106988872ns5:PlantMachinery2024-03-3106988872ns5:ComputerEquipment2024-03-3106988872ns5:PlantMachinery2025-03-3106988872ns5:ComputerEquipment2025-03-3106988872ns5:PlantMachinery2024-03-3106988872ns5:ComputerEquipment2024-03-3106988872ns5:WithinOneYearns5:CurrentFinancialInstruments2025-03-3106988872ns5:WithinOneYearns5:CurrentFinancialInstruments2024-03-3106988872ns10:Director222024-03-3106988872ns10:Director222023-03-3106988872ns10:Director222024-04-012025-03-3106988872ns10:Director222023-04-012024-03-3106988872ns10:Director222025-03-3106988872ns10:Director222024-03-31
REGISTERED NUMBER: 06988872 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025

FOR

MEDICAL TALENT LIMITED

MEDICAL TALENT LIMITED (REGISTERED NUMBER: 06988872)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025




Page

Company Information 1

Statement of Financial Position 2

Notes to the Financial Statements 3


MEDICAL TALENT LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 MARCH 2025







DIRECTORS: J O'Brien
Ms D J Morris
E Urquhart





REGISTERED OFFICE: 10 Warwick Park
TUNBRIDGE WELLS
Kent
TN2 5TB





REGISTERED NUMBER: 06988872 (England and Wales)





ACCOUNTANTS: Wells Associates
Ground Floor Oakhurst House
77 Mount Ephraim
Tunbridge Wells
Kent
TN4 8BS

MEDICAL TALENT LIMITED (REGISTERED NUMBER: 06988872)

STATEMENT OF FINANCIAL POSITION
31 MARCH 2025

2025 2024
Notes £    £   
FIXED ASSETS
Tangible assets 4 1,629 1,400

CURRENT ASSETS
Debtors 5 10,200 57,934
Cash at bank 276,323 283,278
286,523 341,212
CREDITORS
Amounts falling due within one year 6 (70,182 ) (75,930 )
NET CURRENT ASSETS 216,341 265,282
TOTAL ASSETS LESS CURRENT
LIABILITIES

217,970

266,682

PROVISIONS FOR LIABILITIES (309 ) (266 )
NET ASSETS 217,661 266,416

CAPITAL AND RESERVES
Called up share capital 50 50
Retained earnings 217,611 266,366
SHAREHOLDERS' FUNDS 217,661 266,416

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 15 December 2025 and were signed on its behalf by:





J O'Brien - Director


MEDICAL TALENT LIMITED (REGISTERED NUMBER: 06988872)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

1. STATUTORY INFORMATION

Medical Talent Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery - 25% on reducing balance
Computer equipment - 33.33% on cost

Property, plant and equipment are measured at cost less accumulated depreciation and any accumulated impairment losses.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 4 (2024 - 4 ) .

MEDICAL TALENT LIMITED (REGISTERED NUMBER: 06988872)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025

4. TANGIBLE FIXED ASSETS
Plant and Computer
machinery equipment Totals
£    £    £   
COST
At 1 April 2024 3,666 5,252 8,918
Additions - 987 987
At 31 March 2025 3,666 6,239 9,905
DEPRECIATION
At 1 April 2024 3,577 3,941 7,518
Charge for year 22 736 758
At 31 March 2025 3,599 4,677 8,276
NET BOOK VALUE
At 31 March 2025 67 1,562 1,629
At 31 March 2024 89 1,311 1,400

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Trade debtors 10,200 53,760
Other debtors - 4,174
10,200 57,934

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Taxation and social security 69,404 75,299
Other creditors 778 631
70,182 75,930

7. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 31 March 2025 and 31 March 2024:

2025 2024
£    £   
Ms D J Morris and J O'Brien
Balance outstanding at start of year 4,174 (3,944 )
Amounts advanced - 8,118
Amounts repaid (4,174 ) -
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year - 4,174

Loans are repayable on demand and interest is charged at a commercial rate at all times the balance exceeds £10,000.